AUG 28, 2026 · JOURNAL ARTICLE
Review: engineering CRISPR nanoparticle hybrid platforms for biofilm-associated antimicrobial resistance: delivery barriers, resistance reprogramming, and translational challenges
Nanotechnology
This is a mechanistic review of an emerging platform concept with no clinical trial data, analyzing barriers and theoretical potential rather than testing efficacy in humans or animals.
Study details
DesignNarrative review